The Arcady Group is proud to have supported the Stop TB Partnership’s vision in transforming care models in high TB burden countries by creating the Re-imagining TB Care website.
I was honored to be invited by USAID (Dr. Amar Shah) and the WHO (Dr. Malik Parmar) to serve as Mewat Evaluation Team Leader for India’s Evaluation of Integrated Digital Adherence Technology (IDAT) For Treatment Support of TB Patients. Our team [Mr. Bruce Thomas (lead), Dr. Shanker Matta, Mr. Bharat Bhushan Dahiya, Dr. Bhavin Vadera, Dr. Srikrishna S R, Dr. Yogesh Gurav, Dr. […]
The Arcady Group, LLC, a consulting company that works to enhance patient and disease management by addressing the challenges of medication non-adherence, has been awarded a grant from the Bill & Melinda Gates Foundation to continue Arcady’s activities to improve TB medication adherence and TB treatment outcomes. Under this most recent grant, the third from […]
The Arcady Group’s work is collaborative in nature. We know that radical change in global health only comes from multiple stakeholder groups coming together with a shared vision and commitment to action. The Stop TB Partnership recently published a news article on their site entitled, “Stop TB Partnership’s TB REACH initiative funds innovation and fosters […]
We are pleased to announce the publication of “Usability of a Medication Event Reminder Monitor System (MERM) by Providers and Patients to Improve Adherence in the Management of Tuberculosis” in the International Journal of Environmental Research and Public Health. This contributes to the growing body of evidence supporting scale up on the Bill & Melinda Gates Foundation-funded, […]